title: P2X(4) receptors mediate ATP-induced calcium influx in human vascular endothelial cells.
abstract: ATP induces Ca(2+) influx across the cell membrane and activates release from intracellular Ca(2+) pools in vascular endothelial cells (ECs). Ca(2+) signaling leads to the modification of a variety of EC functions, including the production of vasoactive substances such as nitric oxide and prostacyclin. However, the molecular mechanisms for ATP-induced Ca(2+) influx in ECs have not been thoroughly clarified. Here we demonstrate evidence that a P2X(4) receptor for an ATP-gated cation channel is predominantly expressed in human ECs and is involved in the ATP-induced Ca(2+) influx. Northern blot analysis distinctly showed the expression of P2X(4) mRNA in human ECs cultured from the umbilical vein, aorta, pulmonary artery, and skin microvessels. Competitive PCR revealed that P2X(4) mRNA expression was much higher in ECs than was the expression of other subtypes, including P2X(1), P2X(3), P2X(5), and P2X(7). Treatment of ECs with antisense oligonucleotides designed to target the P2X(4) receptor decreased the P2X(4) mRNA and protein levels to approximately 25% of control levels and markedly prevented the ATP-induced Ca(2+) influx.
authors.affiliation: Department of Biomedical Engineering, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
authors.forename: R
authors.initials: R
authors.lastname: Korenaga
authors.forename: A
authors.initials: A
authors.lastname: Kamiya
authors.forename: Z
authors.initials: Z
authors.lastname: Qi
authors.forename: M
authors.initials: M
authors.lastname: Sokabe
authors.forename: J
authors.initials: J
authors.lastname: Ando
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology / Q000502:physiology*; D000595:Amino Acid Sequence; D001011:Aorta; D015153:Blotting, Western; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D003001:Cloning, Molecular; D004533:Egtazic Acid / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008833:Microcirculation; D008969:Molecular Sequence Data; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology; D010446:Peptide Fragments / Q000276:immunology; D011651:Pulmonary Artery; D012333:RNA, Messenger / Q000235:genetics; D018048:Receptors, Purinergic P2 / Q000032:analysis / Q000235:genetics* / Q000502:physiology; D058469:Receptors, Purinergic P2X; D058848:Receptors, Purinergic P2X4; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012867:Skin / Q000098:blood supply; D014158:Transcription, Genetic; D014471:Umbilical Veins
chemical_list: D020319:Oligodeoxyribonucleotides, Antisense; C548226:P2RX4 protein, human; D010446:Peptide Fragments; D012333:RNA, Messenger; D018048:Receptors, Purinergic P2; D058469:Receptors, Purinergic P2X; D058848:Receptors, Purinergic P2X4; D004533:Egtazic Acid; D000255:Adenosine Triphosphate; D002118:Calcium